Legal status by country
Is Nesfatin-1 legal?
Written by Aaron CuhaReviewed Sep 2026
How Nesfatin-1 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule |
| Note | A peptide fragment the body produces, not a product. No approved or investigational drug targets it, and no receptor has been definitively identified to target. Every registered human study located measures circulating nesfatin-1 as an observational biomarker. | Not a medicinal product. No licensed or investigational agent acts on this pathway. | Not a therapeutic good. No registered or investigational agent acts on this pathway. | Not a drug product. No authorised or investigational agent acts on this pathway. |
US FDA status: Nesfatin-1 is an endogenous peptide fragment and is not a medicine. There is no approved product, no investigational product, and no registered interventional trial in which nesfatin-1 is the intervention.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.